I believe the pilot program is good for our chances, even though I also think a rushed review/AI program is not a good idea for vetting drug candidates. That doesn't mean that blarcamesine wouldn't get approved in a traditional review -- I just think the politics of the new program are favorable to us, assuming we get in.
Market Data 
Markets 
AI
